GenScript publishes article that demonstrates how cPass can be automated and applied to semi-quantitative sample analysis based on feasibility study of cPass sVNT on Agility platform
GenScript recently published an article in Vaccine (Elsevier Publishing) that demonstrates how cPass can be automated and applied to semi-quantitative sample analysis with some interesting data depicting the benefits and potential for their semi-quantitative assay. The study describes an approach for accurate quantification of neutralizing antibodies using the cPass sVNT with an automated workflow on […]
Read MoreZEUS receives FDA EUA approval for SARS-SoV-2 Tests on Dynex Instruments
ZEUS has received FDA authorization to run the ZEUS ELISA SARS-SoV-2 Total Antibody Test System using the Dynex Agility®, Dynex DSX® or Dynex DS2® Automated ELISA Systems. Learn More. The SARS-CoV-2 IgG Test System was first granted EUA in October of 2020 to run using the Dynex Agility® Automated ELISA System. The FDA has extended this EUA […]
Read More